Fiboxib P Tablet is a combination medication containing Etoricoxib 60mg and Paracetamol 325mg, designed to provide effective relief from pain and inflammation. Etoricoxib is a selective COX-2 inhibitor that works by reducing the production of prostaglandins, substances responsible for inflammation and pain, thereby alleviating symptoms associated with conditions like osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain. Paracetamol, a widely used analgesic and antipyretic, complements Etoricoxib by providing additional pain relief and reducing fever through central inhibition of prostaglandin synthesis. The synergistic effect of these two active ingredients makes Fiboxib P Tablet suitable for managing moderate to severe pain where inflammation is a significant component. This combination is often preferred for patients who require potent analgesia with a lower risk of gastrointestinal side effects compared to traditional non-selective NSAIDs. Fiboxib P should be used under medical supervision, especially in individuals with a history of cardiovascular disease, liver or kidney impairment, or gastrointestinal issues. It is important to adhere to the prescribed dosage and duration to minimize potential adverse effects. Overall, Fiboxib P Tablet offers a balanced approach to pain management by combining anti-inflammatory and analgesic properties in a single formulation.